3//SEC Filing
Genexine Inc. 3
Accession 0001209191-21-048447
CIK 0001509261other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 5:23 PM ET
Size
5.3 KB
Accession
0001209191-21-048447
Insider Transaction Report
Form 3
Rezolute, Inc.RZLT
Genexine Inc.
10% Owner
Holdings
Series AA Preferred Stock
Exercise: $0.22→ Common Stock (56,818,175 underlying)
Footnotes (1)
- [F1]Reporting Person acquired 1,250,000 shares of Issuer's Series AA Preferred Stock on January 30, 2019. Each share of the Issuer's Series AA Preferred Stock is convertible into shares of the Issuer's Common Stock at a ratio of 45.45454 shares of Common Stock for one share of Series AA Preferred Stock ("Conversion Rate") at the holder's election and has no expiration date. The Series AA Preferred Stock will automatically convert, at the Conversion Rate, into Common Stock (i) at any time upon the vote or consent of the holders of two thirds of the voting power of the then outstanding Series AA Preferred Stock or (ii) the amendment to Issuer's Certificate of Incorporation to increase the number of shares of Common Stock authorized to be issued to at least 500,000,000 shares of Common Stock.
Documents
Issuer
Rezolute, Inc.
CIK 0001509261
Entity typeother
IncorporatedKorea, Republic of
Related Parties
1- filerCIK 0001834377
Filing Metadata
- Form type
- 3
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 5:23 PM ET
- Size
- 5.3 KB